Targeting vacuolar H+-ATPases as a new strategy against cancer

Cancer Research

Volumn 67, Issue 22, 2007, Pages 10627-10630

  Fais, Stefano ^a   De Milito, Angelo ^a   You, Haiyan ^b   Qin, Wenxin ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; ANTINEOPLASTIC AGENT; MATRIX METALLOPROTEINASE; PROTON PUMP INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

APOPTOSIS; CANCER THERAPY; CELL VACUOLE; CYTOTOXICITY; DRUG TARGETING; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; MEMBRANE; METASTASIS; MICROENVIRONMENT; PH; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL MEMBRANE; HUMANS; HYDROGEN-ION CONCENTRATION; IONS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTON-TRANSLOCATING ATPASES; REACTIVE OXYGEN SPECIES; VACUOLES;

EID: 36349001899     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1805     Document Type: Review

References (28)

1. Raghunand N, Mahoney B, van Sluis R, Baggett B, Gillies RJ. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia 2001;3:227-35.
2. Morita T, Nagaki T, Fukuda I, Okumura K. Clastogenicity of low pH to various cultured mammalian cells. Mutat Res 1992;268:297-305.
3. Martinez-Zaguilan R, Seftor EA, Seftor RE, et al. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996;14:176-86.
4. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
5. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9.
6. Newell K, Franchi A, Pouyssegur J, Tannock I. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc Natl Acad Sci U S A 1993;90:1127-31.
7. Yamagata M, Hasuda K, Stamato T, Tannock IF. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 1998;77:1726-31.
8. Nishi T, Forgac M. The vacuolar (H+)-ATPases - nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002;3:94-103.
9. Sennoune SR, Bakunts K, Martínez GM, et al. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 2004;286:1443-52.
10. +-ATPase in cancer biology. Cell Biochem Biophys 2004;40:185-206.
11. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006;66:6699-707.
12. Montcourrier P, Mangeat PH, Valembois C, et al. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci 1994;107:2381-91.
13. Rozhin J, Sameni M, Ziegler G, Sloane BF. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 1994;54:6517-25.
14. Johnson LL, Pavlovsky AG, Johnson AR, et al. A rationalization of the acidic pH dependence for stromelysin-1 (matrix metalloproteinase-3) catalysis and inhibition. J Biol Chem 2000;275:11026-33.
15. Kato Y, Lambert CA, Colige AC, et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem 2005;280:10938-44.
16. Lu X, Qin W, Li J, et al. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 2005;65:6843-9.
17. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
18. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
19. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387-92.
20. De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 2005;1:779-86.
21. Murakami T, Shibuya I, Ise T, et al. Elevated expression of vacuolar proton pump genes and cellular pH in cisplatin resistance. Int J Cancer 2001;93:869-74.
22. +-ATPase c subunit gene (ATP6L) in response to anticancer agents. J Biol Chem 2002;277:36534-43.
23. Raghunand N, He X, van Sluis R, et al. Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer 1999;80:1005-11.
24. Luciani F, Spada M, De Milito A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004;96:1702-13.
25. De Milito A, Iessi E, Logozzi MA, et al. Proton pump inhibitors induce apoptosis of human B cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 2007;67:5408-17.
26. Lugini L, Matarrese P, Tinari A, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006;66:3629-38.
27. Kusuzaki K, Murata H, Matsubara T, et al. Acridine orange could be an innovative anticancer agent under photon energy. In Vivo 2007;21:205-14.
28. Andreev OA, Dupuy AD, Segala M, et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci U S A 2007;104:7893-8.